Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05964829

Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis

A Crossover Study Evaluating the Impact of the Cionic Neural Sleeve on Mobility, Disability, Fall Risk, and Physical Activity in Multiple Sclerosis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
14 (estimated)
Sponsor
Cionic, Inc. · Industry
Sex
All
Age
22 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to support the clinical value of the Cionic Neural Sleeve for individuals diagnosed with multiple sclerosis (MS).

Detailed description

The randomized within-participants crossover 12-week study aims to demonstrate the clinical impact of the Cionic Neural Sleeve for individuals diagnosed with MS. Physical measurements, performance-based tests, and questionnaire responses will be recorded. These include physical activity recorded by the Cionic Neural Sleeve; in-person tests measuring disability, spasticity and balance; and questionnaires gauging perceived walking ability, quality of life, and physical and psychological impact of MS. All participants will be assigned a Cionic Neural Sleeve on the most impacted leg for 6 weeks, and prescribed a home-based intervention of 15 minutes of walking for 5 days a week for 12 weeks. The Cionic Neural Sleeve will be worn for 6 weeks of the study while following the walking program. Participants will be randomized to one of two groups: A or B. Group A will follow the walking program and wear the Neural Sleeve to receive stimulation assisted walking from the Neural Sleeve for 6 weeks. Group B will follow the walking program for 6 weeks. After 6 weeks, participants in each group will cross over to the other group.

Conditions

Interventions

TypeNameDescription
DEVICECionic Neural Sleeve NS-100The Cionic Neural Sleeve applies functional electrical stimulation as subjects walk to help contract appropriate muscles at appropriate times. The Cionic Neural Sleeve will be worn for 6 weeks.
BEHAVIORALWalking Program15 minutes of walking for 5 days per week for 6 weeks

Timeline

Start date
2023-09-04
Primary completion
2026-06-01
Completion
2026-07-01
First posted
2023-07-28
Last updated
2025-09-24

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05964829. Inclusion in this directory is not an endorsement.